Nanoparticles use magnetoelectricity to target and eradicate cancer cells.

Autor: Bryant JM, Stimphil E, Andre V, Shotbolt M, Zhang E, Estrella V, Husain K, Weygand J, Marchion D, Lopez AS, Abrahams D, Chen S, Abdel-Mottaleb M, Conlan S, Oraiqat I, Khatri V, Guevara JA, Pilon-Thomas S, Redler G, Latifi K, Raghunand N, Yamoah K, Hoffe S, Costello J, Frakes JM, Liang P, Khizroev S, Gatenby RA, Malafa M

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.

Intricacies of Human-AI Interaction in Dynamic Decision-Making for Precision Oncology: A Case Study in Response-Adaptive Radiotherapy.

Autor: Niraula D, Cuneo KC, Dinov ID, Gonzalez BD, Jamaluddin JB, Jin JJ, Luo Y, Matuszak MM, Ten Haken RK, Bryant AK, Dilling TJ, Dykstra MP, Frakes JM, Liveringhouse CL, Miller SR, Mills MN, Palm RF, Regan SN, Rishi A, Torres-Roca JF, Yu HM, El Naqa I

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Apr 30. Date of Electronic Publication: 2024 Apr 30.

Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.

Autor: Taniguchi CM; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Frakes JM; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Aguilera TA; Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, USA., Palta M; Department of Radiation Oncology, Duke Cancer Institute, Durham, NC, USA., Czito B; Department of Radiation Oncology, Duke Cancer Institute, Durham, NC, USA., Bhutani MS; Department of Gastroenterology Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colbert LE; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abi Jaoude J; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bernard V; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pant S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tzeng CD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kim DW; Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Malafa M; Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Costello J; Department of Diagnostic Imaging and Interventional Radiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Mathew G; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rebueno N; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Koay EJ; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Das P; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ludmir EB; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wolff RA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beddar S; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sawakuchi GO; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moningi S; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Slack Tidwell RS; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thall PF; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beardsley RA; Galera Therapeutics, Malvern, PA, USA., Holmlund J; Galera Therapeutics, Malvern, PA, USA., Herman JM; Department of Radiation Oncology, Radiation Medicine, Zucker School of Medicine at Hofstra/Northwell, Lake Success, Hempstead, NY, USA., Hoffe SE; Department of Radiation Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: Sarah.Hoffe@moffitt.org.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Dec; Vol. 24 (12), pp. 1387-1398.

Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.

Autor: Kis B; Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida. Electronic address: bela.kis@moffitt.org., Shridhar R; Radiation Oncology, AdventHealth Cancer Institute, Orlando, Florida., Mhaskar R; Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida., Gyano M; Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida., Frakes JM; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida., El-Haddad G; Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida., Choi J; Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida., Kim RD; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida., Hoffe SE; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.

Publikováno v: Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2023 Sep; Vol. 34 (9), pp. 1547-1555. Date of Electronic Publication: 2023 May 18.

Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy.

Autor: Palm RF; Department of Radiation Oncology, Moffitt Cancer Center, Tampa FL, USA. Electronic address: Russell.Palm@moffitt.org., Boyer E; University of South Florida School of Medicine, Tampa, FL, USA., Kim DW; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa FL, USA., Denbo J; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa FL, USA., Hodul PJ; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa FL, USA., Malafa M; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa FL, USA., Fleming JB; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa FL, USA., Shridhar R; Department of Radiation Oncology, Advent Health, Orlando, FL, USA., Chuong MD; Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami FL, USA., Mellon EA; Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Frakes JM; Department of Radiation Oncology, Moffitt Cancer Center, Tampa FL, USA., Hoffe SE; Department of Radiation Oncology, Moffitt Cancer Center, Tampa FL, USA.

Publikováno v: HPB : the official journal of the International Hepato Pancreato Biliary Association [HPB (Oxford)] 2023 Sep; Vol. 25 (9), pp. 1110-1120. Date of Electronic Publication: 2023 May 04.